Business
THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update
JACKSBORO, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (OTC: THCT), a dynamic and growing cannabis company, issued a shareholder update today. To our valued friends and shareholders, We hope that this letter finds you well. We at THCT continue to execute our revitalized strategy and are pleased to provide a corporate update, highlighting our achievements to date and our vision for the future. Corporate Highlights: With the recent acquisitions, we believe the Company’s curren
About this update from Thc Therapeutics, Inc.
[{"type":"image","alt":"THC Therapeutics, Inc.","displaySize":"","headline":null,"caption":"THC Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":45,"url":"https://media.zenfs.com/en/globenewswire.com/34b8001a1c58f3623fb6f6a352430fc8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/h2Qw_waS8pRpvSr1W_p_UA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTYzO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/34b8001a1c58f3623fb6f6a352430fc8","width":300,"height":45}},"lazy":false},{"type":"text","content":"JACKSBORO, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (OTC: THCT), a dynamic and growing cannabis company, issued a shareholder update today.","length":163,"tagName":"p"},{"type":"text","content":"To our valued friends and shareholders,","length":39,"tagName":"p"},{"type":"text","content":"We hope that this letter finds you well. We at THCT continue to execute our revitalized strategy and are pleased to provide a corporate update, highlighting our achievements to date and our vision for the future.","length":212,"tagName":"p"},{"type":"text","content":"Corporate Highlights:","length":21,"tagName":"p"},{"type":"text","content":"With the recent acquisitions, we believe the Company’s current trading price does not yet reflect the underlying value of our operating businesses and assets. We attribute this disconnect primarily to our Expert Market status. As we complete our filings and return to a fully current reporting position, we expect improved visibility, expanded market access, and more efficient price discovery. Our objective is for the public market valuation to more appropriately align with the Company’s operational progress, revenue base, and long-term growth prospects.","length":558,"tagName":"p"},{"type":"text","content":"To enhance our communication with the investment community, we will be hiring an experienced investor relations firm. This partnership will help us effectively convey our value proposition, growth strategy, and operational achievements to current and potential shareholders.","length":274,"tagName":"p"},{"type":"text","content":"Our proactive approach allows us to optimize our portfolio and invest in high-potential opportunities. THC Therapeutics, Inc. remains dedicated to continuously refining our portfolio mix, maximizing returns, and creating sustainable va...